Affiliation: Boston University
- Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive PolicyKevin Outterson
Kevin Outterson is a professor in the School of Law at Boston University, in Massachusetts
Health Aff (Millwood) 35:784-90. 2016..We also explore a second option: The federal government could auction vouchers to the highest bidders and use the money to create an antibiotics innovation fund. ..
- Repairing the broken market for antibiotic innovationKevin Outterson
Kevin Outterson is a professor at the School of Law, Boston University, in Massachusetts, and an associate fellow at the Royal Institute of International Affairs at Chatham House, in London, England, where he coordinates a working group on new business models for antibiotics He is also a member of the Centers for Disease Control and Prevention s Antimicrobial Resistance Working Group, in Atlanta, Georgia
Health Aff (Millwood) 34:277-85. 2015....
- Will longer antimicrobial patents improve global public health?Kevin Outterson
Boston University School of Law, Boston, MA 02215, USA
Lancet Infect Dis 7:559-66. 2007..Conservation efforts to encourage the prudent use of antimicrobial drugs should be directly reimbursed. Patent owners should be compensated for both conservation efforts and valuable innovation...
- Market-based licensing for HPV vaccines in developing countriesKevin Outterson
Boston University School of Law, USA
Health Aff (Millwood) 27:130-9. 2008....
- How Medicare could get better prices on prescription drugsKevin Outterson
Boston University School of Law, Massachusetts, USA
Health Aff (Millwood) 28:w832-41. 2009..These latter options may reduce federal spending without direct government price negotiations...
- Fighting antibiotic resistance: marrying new financial incentives to meeting public health goalsAaron S Kesselheim
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
Health Aff (Millwood) 29:1689-96. 2010..This would increase reimbursement for the appropriate, evidence-based use of antibiotics that also met specific public health goals--such as reducing illness levels while limiting antibiotic resistance...
- Pharmaceutical arbitrage: balancing access and innovation in international prescription drug marketsKevin Outterson
West Virginia University College of Law, USA
Yale J Health Policy Law Ethics 5:193-291. 2005
- Patent buy-outs for global disease innovations for low- and middle-income countriesKevin Outterson
West Virginia University, USA
Am J Law Med 32:159-73. 2006